A comparison of oligonucleotide and cDNA-based microarray systems

被引:93
作者
Mah, N
Thelin, A
Lu, T
Nikolaus, S
Kühbacher, T
Gurbuz, Y
Eickhoff, H
Klöppel, G
Lehrach, H
Mellgård, B
Costello, CM
Schreiber, S
机构
[1] Univ Kiel, Dept Med 1, D-24105 Kiel, Germany
[2] AstraZeneca R&D, S-43183 Molndal, Sweden
[3] Univ Kiel, Dept Pathol, D-24105 Kiel, Germany
[4] Max Planck Inst Mol Genet, D-14195 Berlin, Germany
关键词
noncommercial clone-based microarray system; commercial oligonucleotidebased microarray system; expression screening platform; cross-platform screening;
D O I
10.1152/physiolgenomics.00080.2003
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Large-scale public data mining will become more common as public release of microarray data sets becomes a corequisite for publication. Therefore, there is an urgent need to clarify whether data from different microarray platforms are comparable. To assess the compatibility of microarray data, results were compared from the two main types of high-throughput microarray expression technologies, namely, an oligonucleotide-based and a cDNA-based platform, using RNA obtained from complex tissue (human colonic mucosa) of five individuals. From 715 sequence-verified genes represented on both platforms, 64% of the genes matched in "present" or "absent" calls made by both platforms. Calls were influenced by spurious signals caused by Alu repeats in cDNA clones, clone annotation errors, or matched probes that were designed to different regions of the gene; however, these factors could not completely account for the level of call discordance observed. Expression levels in sequence-verified, platform-overlapping genes were not related, as demonstrated by weakly positive rank order correlation. This study demonstrates that there is only moderate overlap in the results from the two array systems. This fact should be carefully considered when performing large-scale analyses on data originating from different microarray platforms.
引用
收藏
页码:361 / 370
页数:10
相关论文
共 25 条
[1]   Gene-expression profiles predict survival of patients with lung adenocarcinoma [J].
Beer, DG ;
Kardia, SLR ;
Huang, CC ;
Giordano, TJ ;
Levin, AM ;
Misek, DE ;
Lin, L ;
Chen, GA ;
Gharib, TG ;
Thomas, DG ;
Lizyness, ML ;
Kuick, R ;
Hayasaka, S ;
Taylor, JMG ;
Iannettoni, MD ;
Orringer, MB ;
Hanash, S .
NATURE MEDICINE, 2002, 8 (08) :816-824
[2]   Tissue gene expression analysis using arrayed normalized cDNA libraries [J].
Eickhoff, H ;
Schuchhardt, J ;
Ivanov, I ;
Meier-Ewert, S ;
O'Brien, J ;
Malik, A ;
Tandon, N ;
Wolski, EW ;
Rohlfs, E ;
Nyarsik, L ;
Reinhardt, R ;
Nietfeld, W ;
Lehrach, H .
GENOME RESEARCH, 2000, 10 (08) :1230-1240
[3]   A TECHNIQUE FOR RADIOLABELING DNA RESTRICTION ENDONUCLEASE FRAGMENTS TO HIGH SPECIFIC ACTIVITY [J].
FEINBERG, AP ;
VOGELSTEIN, B .
ANALYTICAL BIOCHEMISTRY, 1983, 132 (01) :6-13
[4]   Sharing gene expression data: an array of options [J].
Geschwind, DH .
NATURE REVIEWS NEUROSCIENCE, 2001, 2 (06) :435-438
[5]   HYBRIDIZATION FINGERPRINTING OF HIGH-DENSITY CDNA-LIBRARY ARRAYS WITH CDNA POOLS DERIVED FROM WHOLE TISSUES [J].
GRESS, TM ;
HOHEISEL, JD ;
LENNON, GG ;
ZEHETNER, G ;
LEHRACH, H .
MAMMALIAN GENOME, 1992, 3 (11) :609-619
[6]   Assessment of clone identity and sequence fidelity for 1189 IMAGE cDNA clones [J].
Halgren, RG ;
Fielden, MR ;
Fong, CJ ;
Zacharewski, TR .
NUCLEIC ACIDS RESEARCH, 2001, 29 (02) :582-588
[7]   Historical background and anticipated developments [J].
Jordan, B .
MICROARRAYS, IMMUNE RESPONSES AND VACCINES, 2002, 975 :24-32
[8]   Assessment of the sensitivity and specificity of oligonucleotide (50mer) microarrays [J].
Kane, MD ;
Jatkoe, TA ;
Stumpf, CR ;
Lu, J ;
Thomas, JD ;
Madore, SJ .
NUCLEIC ACIDS RESEARCH, 2000, 28 (22) :4552-4557
[9]   Analysis of matched mRNA measurements from two different microarray technologies [J].
Kuo, WP ;
Jenssen, TK ;
Butte, AJ ;
Ohno-Machado, L ;
Kohane, IS .
BIOINFORMATICS, 2002, 18 (03) :405-412
[10]   HYBRIDIZATION ANALYSES OF ARRAYED CDNA LIBRARIES [J].
LENNON, GG ;
LEHRACH, H .
TRENDS IN GENETICS, 1991, 7 (10) :314-317